DK0448765T3 - Anvendelse af guanidinderivater til fremstilling af et lægemiddel med NPY-antagonistisk virkning - Google Patents
Anvendelse af guanidinderivater til fremstilling af et lægemiddel med NPY-antagonistisk virkningInfo
- Publication number
- DK0448765T3 DK0448765T3 DK90106200.0T DK90106200T DK0448765T3 DK 0448765 T3 DK0448765 T3 DK 0448765T3 DK 90106200 T DK90106200 T DK 90106200T DK 0448765 T3 DK0448765 T3 DK 0448765T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug
- preparation
- guanidine derivatives
- antagonistic effect
- npy antagonistic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP90106200A EP0448765B1 (de) | 1990-03-30 | 1990-03-30 | Verwendung von Guanidinderivaten zur Herstellung eines Arzneimittels mit NPY-antagonistischer Wirkung |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0448765T3 true DK0448765T3 (da) | 1994-09-19 |
Family
ID=8203843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90106200.0T DK0448765T3 (da) | 1990-03-30 | 1990-03-30 | Anvendelse af guanidinderivater til fremstilling af et lægemiddel med NPY-antagonistisk virkning |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0448765B1 (da) |
JP (1) | JPH0789939A (da) |
KR (1) | KR910016329A (da) |
AT (1) | ATE109979T1 (da) |
AU (1) | AU637882B2 (da) |
CA (1) | CA2037433A1 (da) |
DE (1) | DE59006842D1 (da) |
DK (1) | DK0448765T3 (da) |
ES (1) | ES2058651T3 (da) |
HU (1) | HU207945B (da) |
IE (1) | IE65252B1 (da) |
IL (1) | IL97424A (da) |
PT (1) | PT97138A (da) |
ZA (1) | ZA911471B (da) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0672054A4 (en) * | 1991-12-19 | 1996-02-07 | Garvan Inst Med Res | NEW MOLECULE INHIBITING THE BIOLOGICAL FUNCTION OF THE TYROSINE NEUROPEPTIDE. |
US5516653A (en) | 1993-12-28 | 1996-05-14 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof |
US5545549A (en) * | 1994-02-03 | 1996-08-13 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof |
US5989920A (en) * | 1994-12-02 | 1999-11-23 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5 |
US5602024A (en) | 1994-12-02 | 1997-02-11 | Synaptic Pharmaceutical Corporation | DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
AU7692996A (en) * | 1995-12-01 | 1997-06-27 | Ciba-Geigy Ag | Receptor antagonists |
AU7692896A (en) * | 1995-12-01 | 1997-06-27 | Novartis Ag | Quinazolin-2,4-diazirines as NPY receptor antagonist |
AU2764797A (en) * | 1996-05-14 | 1997-12-05 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
ES2176776T3 (es) * | 1996-08-23 | 2002-12-01 | Agouron Pharma | Ligandos del neuropeptido-y. |
FR2754709B1 (fr) | 1996-10-23 | 1999-03-05 | Sanofi Sa | Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition |
AU4772497A (en) * | 1996-10-31 | 1998-05-22 | Novo Nordisk A/S | Constrained somatostatin agonists and antagonists |
US6048900A (en) | 1998-02-13 | 2000-04-11 | Bayer Corporation | Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists |
JP2000510870A (ja) * | 1997-02-14 | 2000-08-22 | バイエル・コーポレーシヨン | Npy5受容体アンタゴニストとしてのアミド類 |
US6245817B1 (en) | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
EP0910565A1 (en) * | 1997-02-14 | 1999-04-28 | Bayer Corporation | Amide derivatives as selective neuropeptide y receptor antagonists |
US6713265B1 (en) | 1997-06-04 | 2004-03-30 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
CA2294898A1 (en) * | 1997-07-03 | 1999-01-14 | Neurogen Corporation | Certain diarylimidazole derivatives; a new class of npy specific ligands |
ES2161594B1 (es) * | 1998-12-17 | 2003-04-01 | Servier Lab | Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
AU2935200A (en) * | 1999-04-30 | 2000-11-17 | Pfizer Products Inc. | Compounds for the treatment of obesity |
AR032895A1 (es) * | 2000-09-20 | 2003-12-03 | Schering Corp | Imidazoles sustituidos como agonistas o antagonistas duales h1 y h3 de histamina |
MXPA03002446A (es) | 2000-09-20 | 2003-06-19 | Schering Corp | Imidazoles substituidos como agonistas o antagonistas duales h1 y h3 de histamina. |
JP2004509871A (ja) | 2000-09-20 | 2004-04-02 | シェーリング コーポレイション | 二重ヒスタミンh1およびh3のアゴニストまたはアンタゴニストとしての置換イミダゾール |
JP2004509869A (ja) | 2000-09-20 | 2004-04-02 | シェーリング コーポレイション | 二重ヒスタミンh1およびh3アゴニストまたはアンタゴニストとしての、置換されたイミダゾール |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0199845B1 (de) * | 1985-04-02 | 1990-08-01 | HEUMANN PHARMA GMBH & CO | Imidazolylalkylguanidinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE3631334A1 (de) * | 1986-09-15 | 1988-03-17 | Heumann Pharma Gmbh & Co | Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
-
1990
- 1990-03-30 DK DK90106200.0T patent/DK0448765T3/da active
- 1990-03-30 DE DE59006842T patent/DE59006842D1/de not_active Expired - Fee Related
- 1990-03-30 ES ES90106200T patent/ES2058651T3/es not_active Expired - Lifetime
- 1990-03-30 EP EP90106200A patent/EP0448765B1/de not_active Expired - Lifetime
- 1990-03-30 AT AT90106200T patent/ATE109979T1/de active
-
1991
- 1991-02-28 ZA ZA911471A patent/ZA911471B/xx unknown
- 1991-03-01 CA CA002037433A patent/CA2037433A1/en not_active Abandoned
- 1991-03-04 AU AU72068/91A patent/AU637882B2/en not_active Ceased
- 1991-03-04 IL IL9742491A patent/IL97424A/en not_active IP Right Cessation
- 1991-03-25 HU HU91979A patent/HU207945B/hu not_active IP Right Cessation
- 1991-03-25 PT PT97138A patent/PT97138A/pt not_active Application Discontinuation
- 1991-03-26 JP JP3061914A patent/JPH0789939A/ja active Pending
- 1991-03-26 IE IE99591A patent/IE65252B1/en not_active IP Right Cessation
- 1991-03-27 KR KR1019910004812A patent/KR910016329A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU637882B2 (en) | 1993-06-10 |
KR910016329A (ko) | 1991-11-05 |
ES2058651T3 (es) | 1994-11-01 |
HUT57044A (en) | 1991-11-28 |
CA2037433A1 (en) | 1991-10-01 |
AU7206891A (en) | 1991-10-03 |
ATE109979T1 (de) | 1994-09-15 |
IL97424A (en) | 1995-05-26 |
DE59006842D1 (de) | 1994-09-22 |
EP0448765A1 (de) | 1991-10-02 |
IL97424A0 (en) | 1992-06-21 |
PT97138A (pt) | 1991-11-29 |
HU910979D0 (en) | 1991-10-28 |
JPH0789939A (ja) | 1995-04-04 |
IE65252B1 (en) | 1995-10-18 |
HU207945B (en) | 1993-07-28 |
IE910995A1 (en) | 1991-10-09 |
EP0448765B1 (de) | 1994-08-17 |
ZA911471B (en) | 1991-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0448765T3 (da) | Anvendelse af guanidinderivater til fremstilling af et lægemiddel med NPY-antagonistisk virkning | |
EA200101156A1 (ru) | ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ | |
SE8804629D0 (sv) | New therapeutically active compounds | |
TR200001891T2 (tr) | ASPB28- İnsan ensülini ve kullanımı. | |
NO870241D0 (no) | Hypoglykemiske tiazolidindioner. | |
ZA888461B (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
DE69011059D1 (de) | Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
GEP19981482B (en) | Use of 1,3 - Oxatiolan Nucleozides Analoges for Treatment of Hepatitis B | |
DK0453127T3 (da) | Behandling af katarakt med 15-keto-prostaglandinforbindelser | |
DK373187A (da) | Laegemiddel med langsom frigivelse af den aktive bestanddel | |
DE3031710C2 (de) | Salze von (+)-catechin, deren herstellung und verwendung sowie diese salze enthaltende pharmazeutische zubereitungen. | |
RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
HU9301253D0 (en) | Medical preparative applicable for treatment of enlarged time of coagulation | |
DE69130586T2 (de) | Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten | |
FI913034A0 (fi) | Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning. | |
DK0647267T3 (da) | Opbevaring af stamceller | |
DE59102245D1 (de) | N-Phenyl-piperidyl-4-amine und diese enthaltende Arzneimittel. | |
DE69326627T2 (de) | Therapeutisches Mittel gegen drohenden Abortus | |
ES2094757T3 (es) | Un factor megacariocitopoyetico. | |
ATE44875T1 (de) | 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln. | |
DK0454429T3 (da) | Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme | |
SE9602262D0 (sv) | New use of derivatives of cystine | |
IT1153183B (it) | Fomulazioni farmaceutiche comprendenti insulina, c-peptide e pro-insulina umani | |
SE9101341D0 (sv) | New medicinal use | |
IT9047505A0 (it) | Siringa ipodermica monouso autobloccante. |